Literature DB >> 4616884

The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.

E C Reifenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4616884     DOI: 10.1016/0090-8258(74)90029-8

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  7 in total

Review 1.  Hormonal therapy in advanced or recurrent endometrial cancer.

Authors:  Fani Kokka; Elly Brockbank; David Oram; Chris Gallagher; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 2.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

Review 3.  Treatment for advanced and recurrent endometrial carcinoma: combined modalities.

Authors:  J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Oncologist       Date:  2010-07-21

4.  Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate.

Authors:  Steve N Caritis; Yang Zhao; Joseph Bettinger; Raman Venkataramanan
Journal:  Am J Obstet Gynecol       Date:  2013-02-20       Impact factor: 8.661

Review 5.  Role of progesterone in endometrial cancer.

Authors:  J Julie Kim; Eloise Chapman-Davis
Journal:  Semin Reprod Med       Date:  2010-01-26       Impact factor: 1.303

Review 6.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

7.  Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.

Authors:  Shujie Yang; Yichen Jia; Xiaoyue Liu; Christopher Winters; Xinjun Wang; Yuping Zhang; Eric J Devor; Adriann M Hovey; Henry D Reyes; Xue Xiao; Yang Xu; Donghai Dai; Xiangbing Meng; Kristina W Thiel; Frederick E Domann; Kimberly K Leslie
Journal:  Oncotarget       Date:  2014-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.